Adherence to and colonization of host tissue are primary steps in bacterial disease. Dental caries and periodontal diseases are tfie most prevalent infections of humans. Both disease processes are initiated by the formation of dental plaque (8, 13, 14, 17, 29) . Streptococcus sanguis is a grampositive bacterium that is found in high numbers in dental plaque (15) . It has been shown to be an initiator of the formation of dental plaque (1, 12) . For these reasons, an understanding of the molecular mechanisms involved in the adhesion of this organism is of great interest.
Recent studies have suggested that the adhesion of S. sanguis is complex, involving hydrophobic (24) , lectin (23) , cell wall protein (19, 27) , and fimbria-mediated interactions (7, (9) (10) (11) . Immunological analysis and analysis of mutants have implicated the peritrichous fimbriae on S. sanguis FW213 in adhesion of this organism to the in vitro tooth model,,saliva-coated hydroxyapatite (7, (9) (10) (11) . Similar analyses halve implicated the type 1 fimbriae of Actinomyces viscosus in adhesion to saliva-coated hydroxyapatite (2, 31) . The precise mechanism(s) of adhesion in both systems remains unknown.
Little is known about the biochemical nature of these gram-positive fimbriae. Part of the difficulty has arisen from the complications in obtaining purified material because of the extremely hydrophobic nature of the fimbriae. In addition, methods that involve dissociation and depolymerization,of fimbriae from gram-negative organisms are ineffective with gram-positive iimbriae (6; tnanuscript in preparation).
This study was undertaken to determine whether an S. sanguis gene encoding the fimbrial subunit could be cloned and expressed in Escherichia coli. Such cloning will allow us to identify and characterize the putative fimbrial subunits * Corresponding author.
and precursors and begin a biochemical and genetic analysis of adhesion.
MATERIALS AND METHODS
Bacterial strains. The strains used or constructed in this study are described in Table 1 . E. coli strains were grown in L broth (5) or Z medium, which contains (per liter) tryptone, 10 g; yeast extract, 1 g; NaCl, 8 g; glucose, 1 g; and 16 N NaOH, 0.2 ml. E. coli cells for bacteriophage lambda infections were grown in NZYM medium with maltose, as described by Maniatis et al. (21) . Tetracycline was added to the media at a concentration of 10 ,ug/ml, and 0.5 mM isopropyl-P-D-thiogalactopyranoside (IPTG) was added when induction was desired. Streptococcal strains were grown in brain heart infusion broth supplemented with 3% yeast extract.
Materials. Brain heart infusion broth was purchased from Difco Laboratories, Detroit, Mich. Restriction endonucleases, lambda DNA, and T4 DNA ligase were purchased from Bethesda Research Laboratories, Gaithersburg, Md. Alkaline phosphatase-conjugated, affinity-purified goat antimouse and goat anti-rabbit immunoglobulin G (heavy and light chain) were obtained from Dynatech Diagnostics, Windham, Maine. Supplies for sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE), crossed immunoelectrophoresis, and dot immunoblots were purchased from Bio-Rad Laboratories, Richmond, Calif. IPTG was purchased from Sigma Chemical Co., St. Louis, Mo.
Plasmid and chromosomal DNA isolation. Covalently closed-circular plasmid DNA was amplified, extracted by SDS lysis, and isolated on cesium chloride-ethidium bromide gradients as described by Clewell (4) . Small quantities of plasmid DNA for screening transformants was isolated by the minilysate procedure as described by Macrina et al. (20) . Chromosomal DNA was isolated by the method of Marmur (22) . Purified DNA and restriction endonuclease digestions 20 representative clones showed that all clones had plasmids with inserts. The average insert size was 3.2 kb. Assuming that the genome of S. sanguis and S. mutans are equivalent in size (5 x 106 base pairs), we estimated, by the Clarke and Carbon formula (3) , that a 3,000 clone library was greater than 99.9% complete.
Antibodies and antigens. Polyclonal antibodies (PAb) raised against whole S. sanguis cells were made as previously described (7) . Antibodies specific for fimbriae (AdAb) were prepared as previously described (7) . When used in experiments, all the antibodies were partially purified by several cycles of 45% ammonium sulfate precipitation.
Colony immunoassays. All recombinant clones were transferred with toothpicks onto sterile nitrocellulose disks placed on L agar plates containing 10 pLg of tetracycline per ml. The plates were incubated overnight at 37°C. The filters were placed over chloroform vapor for 20 min to lyse the cells. The blots were blocked with 3% bovine serum albumin for 2 h at room temperature. A 1:1,000 dilution of PAb in 3% bovine serum albumin-10% fetal calf serum-phosphatebuffered saline was incubated with the blots for 2 h at room temperature. The blots were given six 10-min washes in phosphate-buffered saline and reacted with anti-rabbit immunoglobulin G (heavy and light chains), conjugated with horseradish peroxidase, for 2 h at room temperature. The blots were given six more 10-min washes in phosphatebuffered saline and equilibrated with 10 mM Tris (pH 7.4).
They were developed with 25 ,ug of o-diansidine per ml in 0.01% H202 and 10 mM Tris (pH 7.4). Three milliliters of methanol was used to solubilize the o-diansidine. We stopped the reaction by rinsing the blots in warm water.
Western immunoblotting. (25) . When the A2 gene is expressed, it is lethal to the E. coli host (32) . The Restriction with EcoRI revealed that these plasmids had distinct restriction patterns and that the average size insert was 3.2 kb (data not shown). On the basis of the Clarke and Carbon (3) formula, this library was greater than 99.9% complete.
Expression of S. sanguis antigens. All 4,500 recombinant colonies were screened by colony immunoassays with PAb, the antiserum made against whole FW213 cells that are Ad+ and Fim+. Thirty colonies produced positive reactions of various intensities after growth on nitrocellulose, in situ lysis, and probing with PAb, suggesting that a number of S. sanguis antigens can be expressed in E. coli (Fig. 1A) . When these 30 clones were probed with fimbria-specific antibody, only two clones, VT616 and VT618, were positive (Fig. 1B,  row 3 ). That (Fig. 1B, row 6 ). SK1592 and JA228 were applied as negative controls (Fig. 1B, row 1) . EcoRI restriction analysis of PAb+ clones. Plasmid DNA from the 30 PAb+ clones was cut with EcoRI and electrophoresed in 1.2% agarose gels. The plasmid sizes and patterns of EcoRI restriction sites suggested that 26 of the 30 clones were unique ( Table 2 ). VT616 and VT618 appeared to be the same 6-kb fragment, VT608 and VT609 appeared to be the same 2.8-kb insert, VT619 and VT625 appeared to be the same 1.0-kb fragment, and VT627 and VT628 appeared to be the same 4-kb insert. The identity of the fragments was confirmed by HindlIl restriction endonuclease analysis.
Characterization of immunoreactive proteins. The putative fimbrial clones were induced with IPTG, and extracts of them were electrophoresed in SDS-PAGE gels, electrophoretically transferred to nitrocellulose, and probed with AdAb in a Western immunoblotting assay. The clones, VT616 and VT618, produced an Mr 30,000 protein that, in agreement with the colony immunoassays, reacted in fimbria-specific antibody (Fig. 2) . The protein was produced whether the cells were induced or not, suggesting that the pOP203(A2+) Identification of immunoreactive S. sanguis fimbrial proteins expressed in E. coli. Preparations were subjected to SDS-PAGE, and the proteins were transferred and probed with AdAb. Lanes: 1 and 2, VT616 and VT616 induced with IPTG; 3 and 4, VT618 and VT618 induced with IPTG; 5, E. coli SK1592; 6, fimbriae from lysed preparations of S. sanguis FW213; 7, molecular weight markers.
lactose operator-promoter was not necessary for expression of the gene. Equal numbers of cells of clone VT618 (three experiments) produced more protein when induced than when not induced, suggesting that transcripts were being made from the lactose promoter as well as from some unknown promoter. There was no reaction with the host, SK1592. The relationship between the 30-kilodalton cloned protein and S. sanguis fimbriae is shown in Fig. 2 . One component of the fimbrial preparation was indistinguishable in size from the immunoreactive products of the clones. In addition to this component, a number of larger polypeptides at 43, 53, 72, 74, and 76 kilodaltons, as well as a faint high-molecular-weight smear with a distinguishable band at 200 kilodaltons, were observed. Reactions with monoclonal antibodies and tandem immunoelectrophoresis indicated that all these bands were antigenically identical (data not shown).
Molecular analyses of PAb+ clones. Chromosomal DNA from S. sanguis FW213 and plasmid DNA from some of the PAb+ clones were cleaved with EcoRI and probed with plasmid pVT618 by Southern hybridization (Fig. 3A and B) . A 6-kb EcoRI fragment from S. sanguis FW213 chromosomal DNA and recombinant plasmid DNA from VT616 showed homology with the 6-kb insert from pVT618, providing proof that the pVT618 insert was streptococcal DNA and that the insert in pVT616 was related to the insert in pVT618. All clones showed homology with the 7.2-kb pOP203(A2+) vector. Restriction endonuclease cleavage maps of pVT616 and pVT618 are shown in Fig. 4 . The inserts in both plasmids were 6 kb in size and had no EcoRI sites. Restriction digestion with other enzymes revealed that both inserts had two BamHI sites, one HindIlI site, one SstI site, two SphI sites, and no PvuII sites, further confirming the Southern analysis data that these two inserts are the same fragment of DNA. Restriction mapping, however, indicated that these two inserts had been cloned in reverse orientation. Since the 30-kilodalton protein was expressed in both orientations, the fimbrial promoter must be on the 6-kb EcoRI fragment.
DISCUSSION
The results presented in this paper demonstrate that S. sanguis genes can be cloned into and expressed by E. coli K-12. Certain genes from other streptococcci, notably S. mutants (16, 25, 26) and S. pyogenes (28) , have been found to express in E. coli. We initially screened an S. sanguis genomic library with a broad-spectrum polyclonal antibody that recognized a number of S. sanguis antigens. At the antibody concentration used for screening, only 1% of the clones produced material that was consistently crossreactive with antibody to S. sanguis FW213 whole cells. Restriction enzyme analyses suggested that 26 of the 30 clones were unique.
Two of the clones, VT616 and VT618, expressed a structural gene for a subunit of the adhesion-related fimbriae of S. sanguis. These adhesion-related fimbriae have been named Many higher-molecular-mass polypeptides were noted in the Western immunoblot of type 1 fimbriae. Type 2 fimbriae of A. viscosus have been similarly purified and cloned, and a similar pattern of multiple bands also has been noted (6) . These are the only two reports on the biochemistry of gram-positive fimbriae, but the data do suggest that grampositive fimbriae are very distinct from gram-negative fimbriae. Why the fimbrial epitope appears in multiple bands on SDS-PAGE gels is unknown. Several reasonable suggestions are (i) fimbriae are only partially dissociated in SDS, P-mercaptoethanol, and urea; (ii) the fimbrial peptides may be glycosylated, resulting in a smear; (iii) cell wall material may still be attached to the peptides; and (iv) fimbriae may be composed of nonidentical subunits with an epitope in common. Incomplete dissociation can be ruled out, since native gels produced the same pattern of multiple bands as did denaturing gels (data not shown), suggesting that the multiple bands were not due to incomplete dissociation. Glycosylation remains a viable alternative, since all the bands were sensitive to periodate (manuscript in preparation). We are presently testing the fimbrial preparations with endoglycosidase H to resolve this alternative. Attachment of cell wall material is less likely, since treatment of the fimbrial preparation with mutanolysin had no effect on the number or size of the multiple bands (in preparation). The question of whether fimbriae are composed of nonidentical subunits awaits genetic analysis and sequencing of the fimbrial gene.
This cloned fimbrial gene product will be used to epidemiologically assess the relateness of the S. sanguis fimbrial genes. It is also the first step in understanding the regulation and control of the fimbriae in S. sanguis and can be used to make mutants by marker exchange. In addition, this cloned product will permit production of the protein in high quantity for further biochemical analysis.
